HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gasche, C Articles by Weiss, G Search for Related Content PubMed PubMed Citation Articles by Gasche, C Articles by Weiss, G

Iron, anaemia, and inflammatory bowel diseases

¹ Department of Medicine 4, Division of Gastroenterology and Hepatology, Medical University Vienna, Austria
² Gastrointestinal Laboratory, the Rayne Institute, St. Thomas’ Hospital, London, UK
³ Department of Haematology, University of Wales, College of Medicine, Cardiff, UK
⁴ Department of General Internal Medicine, Clinical Immunology and Infectious Diseases, University of Innsbruck, Austria

Correspondence to:
Correspondence to:
Dr C Gasche
Allgemeines Krankenhaus Wien, Innere Medizin 4, Wahringer Gurtel 18, Vienna, A-1090, Austria; christoph.gasche{at}meduniwien.ac.at

Iron deficiency anaemia is one of the most common disorders in the world. Also, one third of inflammatory bowel disease (IBD) patients suffer from recurrent anaemia. Anaemia has significant impact on the quality of life of affected patients. Chronic fatigue, a frequent IBD symptom itself, is commonly caused by anaemia and may debilitate patients as much as abdominal pain or diarrhoea. Common therapeutic targets are the mechanisms behind anaemia of chronic disease and iron deficiency. It is our experience that virtually all patients with IBD associated anaemia can be successfully treated with a combination of iron sucrose and erythropoietin, which then may positively affect the misled immune response in IBD.

Abbreviations: IBD, inflammatory bowel disease; ID, iron deficiency; IDA, iron deficiency anaemia; TPMT, thiopurine methyltransferase; MCV, mean cell volume; Epo, erythropoietin; ACD, anaemia of chronic disease; RBC, red blood cell; NRAMP-1, natural resistance associated macrophage protein; IFN-, interferon ; TNF-, tumour necrosis factor ; NO, nitric oxide; RES, reticuloendothelial system

Keywords: inflammatory bowel diseases; anaemia; iron deficiency; anaemia of chronic disease; iron sucrose; erythropoietin

This article has been cited by other articles:

				D. Wiese, B. Lashner, and D. Seidner Measurement of Nutrition Status in Crohn's Disease Patients Receiving Infliximab Therapy Nutr Clin Pract, October 1, 2008; 23(5): 551 - 556. [Abstract] [Full Text] [PDF]

				S. F. Clark Iron Deficiency Anemia Nutr Clin Pract, April 1, 2008; 23(2): 128 - 141. [Abstract] [Full Text] [PDF]

				K. Vagianos, S. Bector, J. McConnell, and C. N. Bernstein Nutrition Assessment of Patients With Inflammatory Bowel Disease JPEN J Parenter Enteral Nutr, July 1, 2007; 31(4): 311 - 319. [Abstract] [Full Text] [PDF]

				M. P. Fuhrman Micronutrient Assessment in Long-Term Home Parenteral Nutrition Patients Nutr Clin Pract, December 1, 2006; 21(6): 566 - 575. [Abstract] [Full Text] [PDF]